Statements and progress over the 3 Delphi rounds toward consensus on out-of-hospital transfusion protocols
Domain; statement | Median score* (range) (abstaining vote if applicable) | Round 3† | |
---|---|---|---|
Round 1 | Round 2 | ||
1. General oversight and clinical governance | |||
1.1 | 7 (5–7) Accept revised version | ||
1.2 | 7 (2–7) Accept revised version | ||
1.3 | 7 (3–7; 1) Accept revised version | ||
1.4 | 7 (2–7) Accept revised version | ||
1.5 | 7 (2–7) Round 2 (critical commentary) | 7 (5–7) Accept as written | |
1.6 | 7 (2–7) Accept revised version | ||
1.7 | 6 (2–7; 1) Accept revised version | ||
1.8 | 6 (2–7; 2) Round 2 (critical commentary) | 7 (4–7) Round 2 (critical commentary) | Consensus achieved Accept revised version |
1.9 | 7 (5–7) Round 2 (critical commentary) | 6 (4–7) Round 2 (critical commentary) | Consensus achieved Accept revised version |
1.10 | 7 (3–7) Round 2 (critical commentary) | 7 (5–7) Accept as written | |
1.11 | 6 (2–7) Round 2 (critical commentary) | 7 (5–7; 1) Round 2 (critical commentary) | Consensus achieved Accept revised version |
1.12 | New statement | 6 (1–7) Accept revised version | |
1.13 | New statement | 7 (4–7) Accept revised version | |
1.14 | 7 (2–7) Merged with other statement | ||
2. Storage and transport of blood components and products | |||
2.1 | 7 (1–7; 2) Accept revised version | ||
2.2 | 7 (2–7) Accept revised version | ||
2.3 | New statement | 6 (1–7) Round 2 (critical commentary) | Consensus achieved Accept revised version |
2.4 | New statement | 7 (4–7) Accept as written | |
3. Initiation of out-of-hospital transfusion | |||
3.1 | 6 (3–6; 1) Round 2 (critical commentary) | 6 (1–7) Round 2 (critical commentary) | Consensus achieved Accept revised version |
3.2 | 6 (2–7; 1) Accept revised version | ||
3.3 | 6 (1–7; 1) Round 2 (critical commentary) | 6 (3–7; 1) Round 2 (critical commentary) | Consensus achieved Accept revised version |
3.4 | 7 (6–7) Accept as written | ||
3.5 | 4 (1–7) Round 2 (score) | 5 (2–7) Round 2 (score) | Consensus achieved Accept revised version |
3.6 | 7 (1–7; 1) Merged with other statement | ||
3.7 | 6 (1–7) Round 2 (critical commentary) | 6 (4–7) Merged with other statement | |
3.8 | 4 (1–7; 2) Round 2 (score) | 4 (1–7) Merged with other statement | |
4. Types of blood components and products | |||
4.1 | 6 (1–7) Accept revised version | ||
4.2 | 6 (1–7; 3) Round 2 (critical commentary) | 6 (3–7) Accept revised version | |
4.3 | 5 (1–7; 1) Round 2 (score) | 5 (1–7) Round 2 (score) | Consensus achieved Accept revised version |
4.4 | New statement | 6 (5–7) Accept as written | |
4.5 | 5 (1–7; 1) Round 2 (score) | 5 (1–7) Round 2 (score) | Consensus achieved Accept as written |
4.6 | 5 (1–7) Round 2 (score) | 5 (1–7) Round 2 (score) | No consensus |
4.7 | 6 (2–7) Merged with other statement | ||
4.8 | 6 (1–7) Merged with other statement | ||
5. Delivery and monitoring of out-of-hospital transfusion | |||
5.1 | 7 (5–7) Round 2 (critical commentary) | 7 (5–7) Accept as written | |
5.2 | 7 (1–7; 1) Accept revised version | ||
5.3 | 7 (1–7) Accept revised version | ||
5.4 | 7 (5–7) Accept as written | ||
5.5 | 6 (1–7; 1) Accept revised version | ||
5.6 | New statement | 7 (4–7) Accept as written | |
5.7 | 7 (2–7) Merged with other statement | ||
6. Indications for and use of transfusion adjuncts | |||
6.1 | 7 (5–7) Accept revised version | ||
6.2 | 7 (5–7) Accept revised version | ||
6.3 | 6 (4–7) Accept revised version | ||
6.4 | 7 (5–7; 1) Accept revised version | ||
7. Resuscitation targets to guide transfusion | |||
7.1 | 6 (4–7) Accept revised version | ||
7.2 | 6 (4–7) Accept revised version | ||
7.3 | New statement | 5 (2–7; 1) Round 2 (score) | No consensus |